Approval · Notice of Compliance 32030 · 2023
DOPTELET: Notice of Compliance 32030
Issued November 3, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32030
- Date
- November 3, 2023
- Company
- Swedish Orphan Biovitrum Ab (Publ)Stockholm, --, Sweden
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOPTELET | 02542706 | Marketed |
Medicinal ingredients
- AVATROMBOPAG MALEATE 20 MG per TAB